Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials

Ruff, D.D.; Ford, J.H.; Tockhorn-Heidenreich, A.; Stauffer, V.L.; Govindan, S.; Aurora, S.K.; ... ; Goadsby, P.J. (2019)

Article / Letter to editor

• episodic migraine
• galcanezumab
• LY2951742
• phase 3
• preventive failure

• All authors: Ruff, D.D.; Ford, J.H.; Tockhorn-Heidenreich, A.; Stauffer, V.L.; Govindan, S.; Aurora, S.K.; Terwindt, G.M.; Goadsby, P.J.
• Date: 2019-12-02
• Journal: European Journal of Neurology
• DOI: doi:10.1111/ene.14114